A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer.

Delays to cancer surgery and other treatment caused by the Covid-19 crisis could result in thousands of additional deaths linked to the pandemic in England, a major new study reports.

Researchers at the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research, London are calling on NHS staff to answer a survey about their wellbeing during the COVID-19 crisis. 

The NIHR BRC at The Royal Marsden and the ICR, will be supporting an innovative new study at The Royal Marsden. 

Researchers at The Royal Marsden NHS Foundation Trust and Francis Crick Institute, and funded by The Royal Marsden Cancer Charity, are launching a five-year study with over 1200 cancer patients, analysing the impact of COVID-19 and how cancer treatment interacts with the virus. 

Researchers at The Royal Marsden and The Institute of Cancer Research, London (ICR), will be expanding world-leading research into liquid biopsies to support prompt cancer diagnosis and treatment despite the diagnostic capacity constraints in place during to the COVID 19 pandemic. 

In response to the COVID-19 pandemic, radical changes have been made to radiotherapy treatments for cancer patients. 

Researchers from The Royal Marsden NHS Foundation Trust and St George’s University of London Hospital will be collaborating on a research project to investigate how COVID-19 affects cancer patients, how long it takes for them to clear the virus and whether antibody tests are also useful in the cancer population. 

Scientists have created a dynamic database driven by artificial intelligence which is collecting together the world’s research on coronavirus in a single online space.

The NIHR Biomedical Research Centre at The Royal Marsden and Institute for Cancer Research will be supporting several critical studies, launched by The Royal Marsden at an unprecedented pace to investigate the impact of COVID-19 on cancer treatment and care.